BlueCrest Capital Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,800
Closed -$226K 257
2023
Q1
$226K Buy
+2,800
New +$225K 0.01% 247
2019
Q1
Sell
-61,849
Closed -$2.54M 1243
2018
Q4
$2.54M Buy
+61,849
New +$2.54M 0.13% 117
2018
Q3
Sell
-9,067
Closed -$360K 1628
2018
Q2
$360K Buy
+9,067
New +$349K 0.01% 1006
2017
Q3
Sell
-36,089
Closed -$1.64M 963
2017
Q2
$1.64M Buy
+36,089
New +$1.59M 0.06% 372
2016
Q4
Sell
-14,597
Closed -$567K 756
2016
Q3
$567K Buy
+14,597
New +$551K 0.02% 488
2015
Q2
Sell
-95,436
Closed -$3.15M 842
2015
Q1
$3.15M Buy
+95,436
New +$2.93M 0.17% 171

Other funds holding HOLX

BlueCrest Capital Management's HOLX Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Hologic (HOLX) in Q2 2023, closing a stake of 2,800 shares — an estimated $226K sold.

BlueCrest Capital Management first reported a position in HOLX in Q1 2015 and held it in 6 quarters. The position peaked at $3.15M in Q1 2015. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • BlueCrest Capital Management reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 2,800 Hologic shares in Q2 2023, an estimated $226K.
  • BlueCrest Capital Management first reported a position in Hologic in Q1 2015 and held it in 6 quarters.
  • BlueCrest Capital Management's Hologic position peaked at $3.15M in Q1 2015.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.